EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pan-cancer analysis of the immunological and oncogenic roles of ATAD2 with verification in papillary thyroid carcinoma

Zhecheng Li, Yaxin Zhao, Peng Huang, Zhaoyi Wu, Dengjie Ouyang, Adolphus Osei Nyarko, Lei Ai, Zhejia Zhang, Shi Chang

Scientific Reports · 2024

DOI: 10.1038/s41598-024-73274-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Zhecheng Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, ATPases Associated with Diverse Cellular Activities, Thyroid Neoplasms, DNA-Binding Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Research and Innovation Project Foundation for Graduate in Hunan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ATAD2 (ATPase Family AAA Domain-Containing 2) is highly expressed across varies tumor types, yet its common roles in tumor progression and immune interaction remain unclear. We analyzed the expression and alteration profiles of ATAD2, along with its diagnostic and prognostic role in pan-cancer, utilizing TCGA, GTEx, CPTAC, HPA, and cBioPortal databases. Furthermore, we examined the relationship between ATAD2 and immune infiltration utilizing single-cell sequencing data and TCGA database. Additionally, the expression and oncogenic functions of ATAD2 were verified in papillary thyroid carcinoma (PTC) through MTT, wound-healing, transwell, and flow cytometry assays. Our results revealed significant overexpression of ATAD2 in most cancers, strongly associated with poor prognosis. Amplification was the most frequent alteration type of ATAD2, with its mutation correlating with improved overall survival. ATAD2 was positively correlated with multiple inhibitory immune checkpoints and closely associated with the immunosuppressive microenvironment, particularly in PTC. In vitro experiments demonstrated that ATAD2 promoted the proliferation, migration, and invasion of PTC cells by activating the PI3K-AKT pathway and modulating the G1/S cell cycle checkpoint. Collectively, ATAD2 holds promise as a biomarker for pan-cancer diagnosis and prognosis, as well as a predictor of immunotherapeutic responsiveness and a therapeutic target to enhance the efficacy of existing anti-tumor immune therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Cancer, PapillaryATPases Associated with Diverse Cellular ActivitiesThyroid NeoplasmsDNA-Binding ProteinsHumansPrognosisCell ProliferationCell Line, TumorTumor MicroenvironmentGene Expression Regulation, NeoplasticCell MovementBiomarkers, TumorMutationMaleFemale

Stichwörter der Autor:innen

ATAD2Pan-cancerPapillary thyroid carcinomaTherapeutic targetTumor immune microenvironment

Substanzen

ATAD2 protein, humanATPases Associated with Diverse Cellular ActivitiesDNA-Binding ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of General Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Department of Thyroid and Breast Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Human Normal University, Changsha, 410008, China.
  • Department of General Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China. zhangzhejia@csu.edu.cn.
  • Department of General Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China. changshi@csu.edu.cn.

Förderung

  • The Research and Innovation Project Foundation for Graduate in Hunan Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, Z., Zhao, Y., Huang, P., Wu, Z., Ouyang, D., Nyarko, A. O., Ai, L., Zhang, Z., & Chang, S. (2024). Pan-cancer analysis of the immunological and oncogenic roles of ATAD2 with verification in papillary thyroid carcinoma. Scientific Reports. https://doi.org/10.1038/s41598-024-73274-2

Vancouver

Li Z, Zhao Y, Huang P, Wu Z, Ouyang D, Nyarko AO, et al. Pan-cancer analysis of the immunological and oncogenic roles of ATAD2 with verification in papillary thyroid carcinoma. Scientific Reports. 2024. doi:10.1038/s41598-024-73274-2

BibTeX
@article{Li2024,
  author = {Li, Zhecheng and Zhao, Yaxin and Huang, Peng and Wu, Zhaoyi and Ouyang, Dengjie and Nyarko, Adolphus Osei and Ai, Lei and Zhang, Zhejia and Chang, Shi},
  title = {Pan-cancer analysis of the immunological and oncogenic roles of ATAD2 with verification in papillary thyroid carcinoma},
  journal = {Scientific Reports},
  year = {2024},
  doi = {10.1038/s41598-024-73274-2}
}
Kostenlos starten →